Related Experiment Video
Updated: Mar 31, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy
Kaspar Broch1, Arne K Andreassen2, Einar Hopp3
1Department of Cardiology , Oslo University Hospital Rikshospitalet , Oslo , Norway ; Faculty of Medicine , K.G. Jebsen Cardiac Research Centre and Center for Heart Failure Research, University of Oslo , Oslo , Norway.
Insights
Extensive diagnostic testing for dilated cardiomyopathy (DCM) offers modest value when initial work-up is inconclusive. Further investigations rarely yield new diagnoses or direct therapeutic changes in DCM patients.
Area of Science:
- Cardiology
- Genetics
- Medical Diagnostics
Background:
- Dilated cardiomyopathy (DCM) presents with left ventricular dilation and dysfunction.
- Etiology and prognosis of DCM are highly heterogeneous, necessitating thorough investigation.
- Standard diagnostic procedures include physical examination, blood tests, echocardiography, and coronary angiography.
Purpose of the Study:
- To evaluate the diagnostic and therapeutic yield of extended investigations in patients with idiopathic DCM.
- To determine the value of tests beyond the standard diagnostic work-up.
Main Methods:
- Prospective recruitment of 102 patients diagnosed with idiopathic DCM.
- Extended work-up included cardiac MRI, exercise testing, right-sided heart catheterization with biopsies, 24-hour ECG, and genetic testing.
- Comparison of findings from extended work-up against initial diagnoses.
Main Results:
- An alternative diagnosis was established in 15% of patients through extended testing.
- Potentially disease-causing mutations were identified in 10% of patients.
- Specific diagnoses included non-compaction cardiomyopathy, systemic inflammatory disease with cardiac involvement, and cardiac amyloidosis. Therapeutic consequences were noted in only 5 cases.
Conclusions:
- The diagnostic and therapeutic yield of extensive additional testing in DCM patients with unclear etiology after initial work-up is modest.
- Extensive testing provides limited additional diagnostic or therapeutic benefit in selected DCM cases.
Objective:
Dilated cardiomyopathy (DCM) is characterised by left ventricular dilation and dysfunction not caused by coronary disease, valvular disease or hypertension. Owing to the considerable aetiological and prognostic heterogeneity in DCM, an extensive diagnostic work-up is recommended. We aimed to assess the value of diagnostic testing beyond careful physical examination, blood tests, echocardiography and coronary angiography.
Methods:
From October 2008 to November 2012, we prospectively recruited 102 patients referred to our tertiary care hospital with a diagnosis of 'idiopathic' DCM based on patient history, physical examination, routine blood tests, echocardiography and coronary angiography. Extended work-up included cardiac MRI, exercise testing, right-sided catheterisation with biopsies, 24 h ECG and genetic testing.
Results:
In 15 patients (15%), a diagnosis other than 'idiopathic' DCM was made based on additional tests. In 10 patients (10%), a possibly disease-causing mutation was detected. 2 patients were found to have non-compaction cardiomyopathy based on MRI findings; 2 patients had systemic inflammatory disease with cardiac involvement; and in 1 patient, cardiac amyloidosis was diagnosed by endomyocardial biopsy. Only in 5 cases did the results of the extended work-up have direct therapeutic consequences.
Conclusions:
In patients with DCM, in whom patient history and routine work-up carry no clues to the aetiology, the diagnostic and therapeutic yield of extensive additional testing is modest.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias

